Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC
Hologic
To prepare for if the current H5N1 outbreak worsens, Hologic will work with the CDC to develop reagents that may be used for H5N1 testing
Articles by Hologic
New Data to Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients with Minimal Risk of Distant Recurrence
Hologic
Study assesses prognostic value of BCI testing and its potential in supporting de-escalation of primary adjuvant endocrine therapy
Improve STI Outcomes and Reduce AMR with RNA Multi-Testing
Hologic
Better testing for M. gen reduces rates of undiagnosed illness and AMR likelihood
First and Only FDA-Cleared Digital Cytology System
Hologic
The Genius™ Digital Diagnostics System for Cervical Cancer Screening Can Help More Accurately Detect Disease
The Role of Cytology in the Fight Against Disease
Hologic
How cytologists continue to meet the ever-increasing need for diagnostic screening
AI Digital Cytology Can Improve Your Lab's Cancer Screening
Hologic
The potential of AI and digitization in transforming cytology in your lab
How Can Clinical Labs Support Comprehensive Cervical Cancer Screening?
Hologic
Pap and HPV testing together is highly sensitive and offers the most comprehensive defense against rising rates of cervical cancer